Clinical trial experience with prophylactic human papillomavirus 6/11/16/18 vaccine in young black women

"Purpose: Human papillomavirus (HPV) is the causative agent of cervical cancer. Black women are disproportionally diagnosed and have higher mortality from cervical cancer in the United States. Here we describe the prophylactic efficacy and safety of a quadrivalent HPV-6/11/16/18 vaccine in blac...

Descripción completa

Detalles Bibliográficos
Autores Principales: Clark, Liana R., Myers, Evan R., Huh, Warner, Joura, Elmar A., Paavonen, Jorma, Perez, Gonzalo, James, Margaret K., Sings, Heather L., Haupt, Richard M., Saah, Alfred J., Garner, Elizabeth I.O.
Formato: Artículo (Article)
Lenguaje:Inglés (English)
Publicado: 2013
Materias:
Acceso en línea:https://repository.urosario.edu.co/handle/10336/22218
https://doi.org/10.1016/j.jadohealth.2012.07.003